Clinical TrialsAtsena Presents Encouraging Long-Term Data in XLRS and LCA1 Atsena Presents Encouraging Long-Term Data in XLRS and LCA1 Read Post »
Clinical TrialsFDA Clears NRX-101 Study in Treatment-Resistant Depression and Suicidality FDA Clears NRX-101 Study in Treatment-Resistant Depression and Suicidality Read Post »
Clinical TrialsEntrada Strengthens Its Duchenne Pipeline With Positive ENTR-601-44 Study R... Entrada Strengthens Its Duchenne Pipeline With Positive ENTR-601-44 Study R... Read Post »
Clinical TrialsIncyte Shows Durable 24-Week Response With Opzelura in Moderate AD Incyte Shows Durable 24-Week Response With Opzelura in Moderate AD Read Post »
Clinical TrialsMirum Plans NDA Submission After Positive Volixibat PSC Results Mirum Plans NDA Submission After Positive Volixibat PSC Results Read Post »
Clinical TrialsJohnson & Johnson Breaks a Two-Decade Silence in Perianal Crohn’s Dis... Johnson & Johnson Breaks a Two-Decade Silence in Perianal Crohn’s Dis... Read Post »
Clinical TrialsAbbVie Sharpens Its IBD Edge With Real-World SKYRIZI and RINVOQ Results AbbVie Sharpens Its IBD Edge With Real-World SKYRIZI and RINVOQ Results Read Post »
Clinical TrialsCytokinetics Shifts the Hypertrophic Landscape: Aficamten Scores in ACACIA ... Cytokinetics Shifts the Hypertrophic Landscape: Aficamten Scores in ACACIA ... Read Post »
Clinical TrialsViridian Therapeutics Tightens Grip on TED Pipeline With REVEAL-2 Milestone Viridian Therapeutics Tightens Grip on TED Pipeline With REVEAL-2 Milestone Read Post »
Clinical TrialsOncolytics Biotech Reports Strong Early Data for Pelareorep in mCRC Oncolytics Biotech Reports Strong Early Data for Pelareorep in mCRC Read Post »
Clinical TrialsLilly Drives Long-Term Stability in UC with Omvoh LUCENT-3 Findings Lilly Drives Long-Term Stability in UC with Omvoh LUCENT-3 Findings Read Post »
Clinical TrialsJohnson & Johnson Doubles Down on IBD Inflammation with Dual-Target The... Johnson & Johnson Doubles Down on IBD Inflammation with Dual-Target The... Read Post »
Clinical TrialsRegeneron and Sanofi Confirm Dupixent Benefits in Eosinophilic Esophagitis Regeneron and Sanofi Confirm Dupixent Benefits in Eosinophilic Esophagitis Read Post »
Clinical TrialsNetwork Analysis Shows CAPLYTA Favored in Adjunctive MDD Treatment Network Analysis Shows CAPLYTA Favored in Adjunctive MDD Treatment Read Post »
Clinical TrialsTakeda’s TAK-881 delivers comparable results to HYQVIA in PID Takeda’s TAK-881 delivers comparable results to HYQVIA in PID Read Post »
Clinical TrialsNanoViricides, Inc. Secures FDA Orphan Designation for NV-387 Measles Thera... NanoViricides, Inc. Secures FDA Orphan Designation for NV-387 Measles Thera... Read Post »
Clinical TrialsBioMarin Highlights VOXZOGO’s Long-Term Benefits on Bone and Growth BioMarin Highlights VOXZOGO’s Long-Term Benefits on Bone and Growth Read Post »
Clinical TrialsAlector Discontinues PROGRESS-AD Trial of Nivisnebart After Futility Analys... Alector Discontinues PROGRESS-AD Trial of Nivisnebart After Futility Analys... Read Post »
Clinical TrialsCorcept Drives Survival Gain in ALS Despite Missing Primary Endpoint Corcept Drives Survival Gain in ALS Despite Missing Primary Endpoint Read Post »
Clinical TrialsTelix Advances TLX597-Tx with Positive Phase 2 Dosimetry Findings Telix Advances TLX597-Tx with Positive Phase 2 Dosimetry Findings Read Post »
Clinical TrialsNovo Nordisk Strikes at the Core of Haemophilia A with Denecimig Breakthrou... Novo Nordisk Strikes at the Core of Haemophilia A with Denecimig Breakthrou... Read Post »
Clinical TrialsNewron Hits a Regulatory Speed Bump as FDA Pauses U.S. Enrollment in ENIGMA... Newron Hits a Regulatory Speed Bump as FDA Pauses U.S. Enrollment in ENIGMA... Read Post »
Clinical TrialsVeradermics Meets Endpoints with Oral VDPHL01 in Pattern Hair Loss Study Veradermics Meets Endpoints with Oral VDPHL01 in Pattern Hair Loss Study Read Post »
Clinical TrialsGilead Leverages Priority Review to Advance Bic/Len in HIV Care Gilead Leverages Priority Review to Advance Bic/Len in HIV Care Read Post »
Clinical TrialsPfizer Sets a New Pace in Multiple Myeloma Treatment with ELREXFIO Pfizer Sets a New Pace in Multiple Myeloma Treatment with ELREXFIO Read Post »
Clinical TrialsImmunome Reports Strong Phase 3 Data, Submits NDA for Varegacestat Immunome Reports Strong Phase 3 Data, Submits NDA for Varegacestat Read Post »
Clinical TrialsFDA Real-Time Trials: AstraZeneca and Amgen Lead Breakthrough FDA Real-Time Trials: AstraZeneca and Amgen Lead Breakthrough Read Post »
Clinical TrialsBoehringer’s survodutide Achieves Up to 16.6% Weight Loss in Phase II... Boehringer’s survodutide Achieves Up to 16.6% Weight Loss in Phase II... Read Post »
Clinical TrialsAbbVie Files Upadacitinib for FDA Approval in Alopecia Areata AbbVie Files Upadacitinib for FDA Approval in Alopecia Areata Read Post »
Clinical TrialsMundipharma Positions REZZAYO as a Steady Shield in Fungal Prevention Study Mundipharma Positions REZZAYO as a Steady Shield in Fungal Prevention Study Read Post »
Clinical TrialsOruka Therapeutics Reports Strong 16-Week Results for ORKA-001 in Psoriasis Oruka Therapeutics Reports Strong 16-Week Results for ORKA-001 in Psoriasis Read Post »
Clinical TrialsIntellia Backs Lonvo-z as One-Time CRISPR Therapy for HAE in Phase 3 HAELO Intellia Backs Lonvo-z as One-Time CRISPR Therapy for HAE in Phase 3 HAELO Read Post »
Clinical TrialsZydus Takes Zintrodiazine to Phase III After DCGI Clearance in India Zydus Takes Zintrodiazine to Phase III After DCGI Clearance in India Read Post »
Clinical TrialsKyowa Kirin, Kura Oncology Dose First Patient in Japan Ziftomenib Study Kyowa Kirin, Kura Oncology Dose First Patient in Japan Ziftomenib Study Read Post »
Clinical TrialsCatalYm Targets the Root of Cancer-Linked Wasting in VINCIT Trial CatalYm Targets the Root of Cancer-Linked Wasting in VINCIT Trial Read Post »
Clinical TrialsNeurocrine Charts a Lower-Steroid Future for CAH With Crinecerfont Data Neurocrine Charts a Lower-Steroid Future for CAH With Crinecerfont Data Read Post »
Clinical TrialsNovo Nordisk Reports Positive PIONEER TEENS Results for Oral Semaglutide Novo Nordisk Reports Positive PIONEER TEENS Results for Oral Semaglutide Read Post »
Clinical TrialsCapricor Reports Phase 3 HOPE-3 Results for Deramiocel in Duchenne Capricor Reports Phase 3 HOPE-3 Results for Deramiocel in Duchenne Read Post »
Clinical TrialsKyverna Advances Miv-cel with Positive Registrational Data in Rare Neurolog... Kyverna Advances Miv-cel with Positive Registrational Data in Rare Neurolog... Read Post »
Clinical TrialsNeurona Aims to Break the Cycle of Drug-Resistant MTLE with Rezanecel Neurona Aims to Break the Cycle of Drug-Resistant MTLE with Rezanecel Read Post »
Clinical TrialsJohnson & Johnson Reinforces Disease Control in gMG with Nipocalimab Johnson & Johnson Reinforces Disease Control in gMG with Nipocalimab Read Post »
Clinical TrialsRoche Advances a New Front in MS Treatment Roche Advances a New Front in MS Treatment Read Post »
Clinical TrialsENSPRYNG Signals a Breakthrough for Roche in MOGAD ENSPRYNG Signals a Breakthrough for Roche in MOGAD Read Post »
Clinical TrialsAfter the U.S. Green Light, Denmark Accelerates Enlivex Allocetra’s Path After the U.S. Green Light, Denmark Accelerates Enlivex Allocetra’s Path Read Post »
Clinical TrialsMerck, Eisai’s LITESPARK-012 Stumbles at the Finish Line in First-Lin... Merck, Eisai’s LITESPARK-012 Stumbles at the Finish Line in First-Lin... Read Post »
Clinical TrialsAstraZeneca Reports Early Proteinuria Reduction With Ultomiris in IgAN Tria... AstraZeneca Reports Early Proteinuria Reduction With Ultomiris in IgAN Tria... Read Post »
Clinical TrialsBicycle Therapeutics Highlights Nuzefatide Progress in Pancreatic Cancer Bicycle Therapeutics Highlights Nuzefatide Progress in Pancreatic Cancer Read Post »
Clinical TrialsLundbeck Highlights Brain Fog Improvements with Eptinezumab Lundbeck Highlights Brain Fog Improvements with Eptinezumab Read Post »
Clinical TrialsAstraZeneca Reports Positive MIRANDA Trial Results for Tozorakimab in COPD AstraZeneca Reports Positive MIRANDA Trial Results for Tozorakimab in COPD Read Post »
Clinical TrialsNew data from United Therapeutics points to earlier action in pulmonary hyp... New data from United Therapeutics points to earlier action in pulmonary hyp... Read Post »
